163 related articles for article (PubMed ID: 14726200)
1. Effects of ligand binding and conformational switching on intracellular stability of human thymidylate synthase.
Berger SH; Berger FG; Lebioda L
Biochim Biophys Acta; 2004 Jan; 1696(1):15-22. PubMed ID: 14726200
[TBL] [Abstract][Full Text] [Related]
2. Structure of human thymidylate synthase suggests advantages of chemotherapy with noncompetitive inhibitors.
Phan J; Steadman DJ; Koli S; Ding WC; Minor W; Dunlap RB; Berger SH; Lebioda L
J Biol Chem; 2001 Apr; 276(17):14170-7. PubMed ID: 11278511
[TBL] [Abstract][Full Text] [Related]
3. Structural analyses of human thymidylate synthase reveal a site that may control conformational switching between active and inactive states.
Chen D; Jansson A; Sim D; Larsson A; Nordlund P
J Biol Chem; 2017 Aug; 292(32):13449-13458. PubMed ID: 28634233
[TBL] [Abstract][Full Text] [Related]
4. Structural determinants for the intracellular degradation of human thymidylate synthase.
Forsthoefel AM; Peña MM; Xing YY; Rafique Z; Berger FG
Biochemistry; 2004 Feb; 43(7):1972-9. PubMed ID: 14967037
[TBL] [Abstract][Full Text] [Related]
5. The means to an end of tumor cell resistance to chemotherapeutic drugs targeting thymidylate synthase: shoot the messenger.
Berg RW; Ferguso PJ; DeMoor JM; Vincen MD; Koropatnick J
Curr Drug Targets; 2002 Aug; 3(4):297-309. PubMed ID: 12102601
[TBL] [Abstract][Full Text] [Related]
6. Human Thymidylate Synthase Inhibitors Halting Ovarian Cancer Growth.
Ferrari S; Severi L; Pozzi C; Quotadamo A; Ponterini G; Losi L; Marverti G; Costi MP
Vitam Horm; 2018; 107():473-513. PubMed ID: 29544641
[TBL] [Abstract][Full Text] [Related]
7. Analysis of mRNA recognition by human thymidylate synthase.
Brunn ND; Dibrov SM; Kao MB; Ghassemian M; Hermann T
Biosci Rep; 2014 Dec; 34(6):e00168. PubMed ID: 25423174
[TBL] [Abstract][Full Text] [Related]
8. Multi-targeted antifolates aimed at avoiding drug resistance form covalent closed inhibitory complexes with human and Escherichia coli thymidylate synthases.
Sayre PH; Finer-Moore JS; Fritz TA; Biermann D; Gates SB; MacKellar WC; Patel VF; Stroud RM
J Mol Biol; 2001 Nov; 313(4):813-29. PubMed ID: 11697906
[TBL] [Abstract][Full Text] [Related]
9. Human thymidylate synthase is in the closed conformation when complexed with dUMP and raltitrexed, an antifolate drug.
Phan J; Koli S; Minor W; Dunlap RB; Berger SH; Lebioda L
Biochemistry; 2001 Feb; 40(7):1897-902. PubMed ID: 11329255
[TBL] [Abstract][Full Text] [Related]
10. The active-inactive transition of human thymidylate synthase: targeted molecular dynamics simulations.
Salo-Ahen OM; Wade RC
Proteins; 2011 Oct; 79(10):2886-99. PubMed ID: 21905113
[TBL] [Abstract][Full Text] [Related]
11. Biomolecular study of human thymidylate synthase conformer-selective inhibitors: New chemotherapeutic approach.
El-Mesallamy HO; El Magdoub HM; Chapman JM; Hamdy NM; Schaalan MF; Hammad LN; Berger SH
PLoS One; 2018; 13(3):e0193810. PubMed ID: 29538414
[TBL] [Abstract][Full Text] [Related]
12. Variants of human thymidylate synthase with loop 181-197 stabilized in the inactive conformation.
Lovelace LL; Johnson SR; Gibson LM; Bell BJ; Berger SH; Lebioda L
Protein Sci; 2009 Aug; 18(8):1628-36. PubMed ID: 19569192
[TBL] [Abstract][Full Text] [Related]
13. Replacement of Val3 in human thymidylate synthase affects its kinetic properties and intracellular stability .
Huang X; Gibson LM; Bell BJ; Lovelace LL; Peña MM; Berger FG; Berger SH; Lebioda L
Biochemistry; 2010 Mar; 49(11):2475-82. PubMed ID: 20151707
[TBL] [Abstract][Full Text] [Related]
14. The identification of thymidylate synthase peptide domains located in the interface region that bind thymidylate synthase mRNA.
Voeller DM; Zajac-Kaye M; Fisher RJ; Allegra CJ
Biochem Biophys Res Commun; 2002 Sep; 297(1):24-31. PubMed ID: 12220503
[TBL] [Abstract][Full Text] [Related]
15. Structural and Functional Characterization of the Human Thymidylate Synthase (hTS) Interface Variant R175C, New Perspectives for the Development of hTS Inhibitors.
Pozzi C; Ferrari S; Luciani R; Costi MP; Mangani S
Molecules; 2019 Apr; 24(7):. PubMed ID: 30959951
[TBL] [Abstract][Full Text] [Related]
16. Human thymidylate synthase with loop 181-197 stabilized in an inactive conformation: ligand interactions, phosphorylation, and inhibition profiles.
Luo B; Repalli J; Yousef AM; Johnson SR; Lebioda L; Berger SH
Protein Sci; 2011 Jan; 20(1):87-94. PubMed ID: 21064161
[TBL] [Abstract][Full Text] [Related]
17. Role of N-terminal residues in the ubiquitin-independent degradation of human thymidylate synthase.
Peña MM; Xing YY; Koli S; Berger FG
Biochem J; 2006 Feb; 394(Pt 1):355-63. PubMed ID: 16259621
[TBL] [Abstract][Full Text] [Related]
18. Crystal structure of a deletion mutant of human thymidylate synthase Delta (7-29) and its ternary complex with Tomudex and dUMP.
Almog R; Waddling CA; Maley F; Maley GF; Van Roey P
Protein Sci; 2001 May; 10(5):988-96. PubMed ID: 11316879
[TBL] [Abstract][Full Text] [Related]
19. Crystal structures of nematode (parasitic T. spiralis and free living C. elegans), compared to mammalian, thymidylate synthases (TS). Molecular docking and molecular dynamics simulations in search for nematode-specific inhibitors of TS.
Jarmuła A; Wilk P; Maj P; Ludwiczak J; Dowierciał A; Banaszak K; Rypniewski W; Cieśla J; Dąbrowska M; Frączyk T; Bronowska AK; Jakowiecki J; Filipek S; Rode W
J Mol Graph Model; 2017 Oct; 77():33-50. PubMed ID: 28826032
[TBL] [Abstract][Full Text] [Related]
20. Crystal structure of the active form of native human thymidylate synthase in the absence of bound substrates.
Deschamps P; Réty S; Bareille J; Leulliot N
Acta Crystallogr F Struct Biol Commun; 2017 Jun; 73(Pt 6):336-341. PubMed ID: 28580921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
